Although high expression in pancreatic carcinoma indicates that KLK6 and 10 could be promising tumour markers, we could not assess the use of KLK6 and KLK10 as serum biomarkers in PDAC. The gene discussed is KLK6; the disease is exocrine pancreatic carcinoma.